Figure 6From: Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimenProfiles of simulated MCV with two dosing regimens. 90% prediction intervals and medians of simulated MCV with HU 7/7 (solid lines) and 5/7 (dotted lines) (n = 10000).Back to article page